Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
Stocks in this Quantisnow insightHealth Care
Historical context for BBNX
Across the 13 sessions after earlier BBNX headlines, the stock closed higher 7 times and lower 6 times, with a median move of 3.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BBNX | SPY |
|---|---|---|---|
| Apr 28, 2026 | Beta Bionics to Present at the Bank of America Securities Health Care Conference | -5.4% | -0.5% |
| Apr 22, 2026 | Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | -0.6% | +1.0% |
| Mar 31, 2026 | Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Careand 1 other headline that session | +1.6% | +2.9% |
| Feb 20, 2026 | Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference | +1.8% | +0.7% |
| Feb 18, 2026 | Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | -2.6% | +0.5% |
| Feb 9, 2026 | UBS initiated coverage on Beta Bionics with a new price target | +6.0% | +0.5% |
Quantisnow market dataNASDAQ
BBNX
Beta Bionics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2025
Get push alerts for BBNX
Full BBNX profile on Quantisnow Follow BBNX and get a push notification the moment its next story breaks.